Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Love Beauty Pro & Medical Brings Cutting-Edge Skin Treatment PRX-T33® to U.S. Market in Partnership with WiQo®, the PRX-T33 Creator from Italy

Love Beauty Professional & Medical is bringing PRX-T33®, a cutting-edge skin treatment, to the U.S. market in partnership with PRX-T33 creator WiQo®, an Italian skin care company headquartered in Venice, Italy.


News provided by

Love Beauty Professional & Medical

Oct 01, 2021, 12:30 ET

Share this article

Share toX

Share this article

Share toX

Love Beauty Professional & Medical is bringing PRX-T33®, a cutting-edge skin treatment, to the U.S. market in partnership with PRX-T33 creator WiQo®.
Love Beauty Professional & Medical is bringing PRX-T33®, a cutting-edge skin treatment, to the U.S. market in partnership with PRX-T33 creator WiQo®.

WOBURN, Mass., Oct. 1, 2021 /PRNewswire-PRWeb/ -- Love Beauty Professional & Medical, a leading distributor and educator of advanced aesthetic technologies, is thrilled to be partnering with WiQo® to bring PRX-T33® to the U.S.!

Love Beauty Pro & Medical has partnered with WiQo to bring this transformative new professional skin treatment to the U.S. market. As the exclusive U.S. distributor, Love Beauty Pro & Medical is working with a team of 50 outside sales representatives and advanced clinical trainers to bring these products to the country's top medspas, dermatology offices and plastic surgeons.

PRX-T33 and other WiQo products are designed to prevent further signs of skin aging and offer natural, long-lasting benefits without invasive measures and without interrupting everyday life.

Post this

With over two million treatments performed worldwide, PRX-T33 and other WiQo products are designed to prevent further signs of skin aging and offer natural, long-lasting benefits without invasive measures and without interrupting everyday life.

WiQo's star treatment is their PRX-T33, for many reasons. Here are just a few:

  • Contains 33% TCA (trichloroacetic acid), kojic acid and the stand-out ingredient: Hydrogen peroxide. Hydrogen peroxide sets this treatment apart from all others! This proprietary blend is what makes PRX-T33 unique.
  • The 15-minute in-office treatment gives patients an immediate glow and long-term collagen stimulation.
  • Does NOT cause skin peeling
  • Is safe for all skin types: Fitzpatrick 1-6
  • Involves no downtime, no pain, no needles, no surgery
  • Targets aging skin, texture, laxity, wrinkles and dull skin for complete rejuvenation on the face or body.
  • Is non-photosensitizing: Can be used in the summer months
  • Stimulates the skin's regenerative process
  • Provides immediate and long-lasting benefits

The real powerhouse key ingredient in PRX-T33 is H2O2 (hydrogen peroxide). Don't be fooled by imitators. Without this key ingredient, the magic doesn't happen.

What can H202 do for patients?
H2O2 is proven to:

  • Accelerate the skin's healing process
  • Stimulate connective tissue regeneration to remodel the dermal extracellular matrix
  • Create an oxygen-rich environment toxic to P. acne bacteria

How does PRX T-33 work?

  • PRX T-33 is applied via topical massage from a skincare professional and followed by an at-home skincare protocol.
  • Session is repeated once per week for four to six sessions.
  • The biological response stimulates fibroblasts, cell proliferation and cell turnover.
  • Fibroblasts produce new collagen and elastin to remodel stressed skin.
  • Skin is tighter, brighter and more hydrated than ever before!

Love Beauty Pro & Medical will soon be announcing some exciting new developments and products being launched in the fourth quarter of 2021 and the first quarter of 2022! These announcements will include an exclusive advanced training program on combination therapy of PRX-T33 with microneedling, which will be held at medical aesthetics practices and aesthetics training sites across the country.

Visit https://lovebeautypro.com/ or call (855) 568-3776 today to learn more about PRX-T33 and how Love Beauty Pro & Medical can help medical aesthetics practices take their services to the next level.

About Love Beauty Professional & Medical
Love Beauty Professional & Medical is committed to the success of aesthetics providers. Their mission is to advance their professional skills and education, empowering providers to administer the highest level of treatments and results for their aesthetics clients.

Love Beauty Professional & Medical is a distributor and advanced aesthetics institute for PRX-T33, PlasmaMD™ and other in-demand, cutting-edge technology and products. For training, support or to grow a professional aesthetics practice, call (855) 568-3776 or complete our contact form today.

Media Contact

Amy Aarons, Love Beauty Professional & Medical, 855-568-3776, [email protected]

SOURCE Love Beauty Professional & Medical

Related Links

http://lovebeautypro.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.